NuVasive Sees 6% Growth In FY15 Revenue - Quick Facts

(RTTNews) - NuVasive, Inc. (NUVA), a medical device company, Tuesday said it expects full-year 2015 revenue to approximate $811 million, reflecting 6 percent year-over-year growth, or 8 percent on a constant currency basis.

The firm expects preliminary fourth quarter 2015 revenue performance of around $215 million. Additionally, the company expects full year 2015 non-GAAP operating profit margin to exceed its previously issued guidance of about 15.2 percent.

NuVasive expects full year 2016 revenue to grow 7 percent year-over-year to $870 million, in line with the mid to high single-digit long-term revenue growth target communicated previously.

The company expects full year 2016 non-GAAP operating profit margin expansion of approximately 100 basis points compared to full year 2015, exclusive of the impact of the Ellipse Technologies acquisition.